$NBIS

Boynton John Wilson IV sold $1.5M of NBIS

Boynton John Wilson IV sold 5,812 shares of Nebius Group N.V. (NBIS) at an average of $253.29 ($246.17–$262.09, $1.47M total) across 10 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Boynton John Wilson IV
Published Jun 15, 2026, 11:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 11:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NBIS
Neutral
medium confidence
Mentioned
$NBIS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NBISNeutralLow
01

Why it matters

A director open-market sale of 5,812 shares (weighted avg ~$253.29) under a pre-arranged 10b5-1 plan is disclosed; this is generally treated as low-signal for fundamentals.

02

Market read

Traders may monitor NBIS for any follow-on insider selling, but the disclosure alone is unlikely to drive a major repricing.

03

What to watch

Consider whether the director’s remaining holdings are large relative to typical liquidity and whether subsequent filings show continued sales beyond the scheduled tranche.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-15 (same day as the sales)

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Nebius Group N.V. (NBIS).

Company-level read

Ticker impact

$NBISNeutralMedium confidence
Context

SEC Form 4 shows director Boynton John Wilson IV sold $1.47M of NBIS shares via a pre-arranged 10b5-1 plan on 2026-06-15.

Expected impact

Likely limited/short-lived impact; watch for follow-on selling or unusual volume around the trade window.

Evidence & confidence

The filing is an open-market sale under a pre-arranged 10b5-1 plan, which typically reduces signaling risk versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, clustered sales can coincide with periods of weaker demand/valuation, so traders may still fade rallies if selling continues.

Key entities

  • Nebius Group N.V.

    Subject of the Form 4 insider transaction disclosure.

  • Boynton John Wilson IV

    Director who executed the open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NBISMed

Nebius stock breaks below $200 as CoreWeave’s debt scare spreads

Nebius Group (NBIS) fell 10.1% to $186.01 on October 14, 2026, breaking its $200 support level. The decline was driven by fears of excessive debt in the AI sector, sparked by CoreWeave (CRWV) bonds yielding near 15%. Nebius's funding costs may rise due to this market sentiment. The company's stock trades at 38x trailing sales and 7x forward sales, with analysts' price targets ranging from $84 to $410.

$NBISMed

Why is Nebius stock sliding today?

Nebius Group NV (NBIS) stock fell 4.1% to $178.4 in pre-open trading, extending losses due to rising borrowing costs, higher bond yields for peer CoreWeave, and Gartner's warning about AI infrastructure spending risks. Insider selling and a bearish stance from short-seller Michael Burry also contributed. The broader tech sector selloff, driven by higher Treasury yields, added pressure.

$NBISMed

Nebius Group (NBIS) Shares Drop 10% Amid Tech Sell-Off; P/S Rati

Nebius Group (NBIS) shares fell 10.08% to $186.01 on October 14, 2026, amid a broader tech sector sell-off. The company's P/S ratio is 38.39, significantly above its historical median and industry norms. Nebius has a GF Score of 52, with strong momentum but weak valuation and financial strength. Insiders have sold $318.2 million in shares over the past year, while some institutional investors have increased their stakes.